Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-12-12 Purchase | 2023-12-14 6:21 pm | Quince Therapeutics Inc. | QNCX | Lamond David Director | 67,881 | $1.0199 | $69,233 | 6,686,387 (Indirect Direct) | View |
| 2023-12-05 Purchase | 2023-12-07 6:30 pm | Quince Therapeutics Inc. | QNCX | Lamond David Director | 57,369 | $1.0133 | $58,134 | 4,316,215 (Indirect Direct) | View |
| 2023-11-29 Purchase | 2023-12-01 1:38 pm | Quince Therapeutics Inc. | QNCX | Lamond David Director | 43,134 | $0.94 | $40,546 | 4,258,846 (Indirect Direct) | View |
| 2023-08-30 Purchase | 2023-08-31 6:42 pm | Quince Therapeutics Inc. | QNCX | Lamond David Director | 82,052 | $1.315 | $107,898 | 4,215,712 (Indirect Direct) | View |
| 2023-08-15 Purchase | 2023-08-17 6:08 pm | Quince Therapeutics Inc. | QNCX | Lamond David Director | 250,000 | $1.3029 | $325,737 | 4,133,660 (Indirect Direct) | View |
| 2022-05-20 Purchase | 2022-05-23 6:18 pm | Applied Molecular Transport Inc. | AMTI | Lamond David Director | 66,500 | $3.1707 | $210,850 | 1,077,519 (Indirect) | View |
| 2021-04-06 Purchase | 2021-04-07 6:47 pm | Applied Molecular Transport Inc. | AMTI | Lamond David Director | 25,000 | $42 | $1,050,000 | 1,011,019 (Indirect) | View |
| 2021-03-24 Purchase | 2021-03-24 9:06 pm | Cortexyme Inc. | CRTX | Lamond David Director | 50,000 | $33.77 | $1,688,500 | 3,683,658 (Indirect Direct) | View |
| 2021-03-04 Purchase | 2021-03-05 5:54 pm | Cortexyme Inc. | CRTX | Lamond David Director | 50,000 | $35.34 | $1,767,057 | 2,098,938 (Indirect Direct) | View |
| 2020-06-04 Purchase | 2020-06-08 6:47 pm | Cortexyme Inc. | CRTX | Lamond David Director | 49,125 | $43.27 | $2,125,795 | 2,048,938 (Indirect Direct) | View |
| 2020-05-15 Purchase | 2020-05-19 6:41 pm | Cortexyme Inc. | CRTX | Lamond David Director | 44,648 | $55.35 | $2,471,251 | 1,999,813 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-05 Option Award | 2024-06-07 9:08 pm | 2025-06-05 2034-06-05 | Quince Therapeutics Inc. | QNCX | Lamond David Director | 27,000 | $0 | 27,000 (Direct) | View |
| 2023-05-24 Option Award | 2023-05-26 5:47 pm | N/A 2033-05-23 | Quince Therapeutics Inc. | QNCX | Lamond David Director | 27,000 | $0 | 27,000 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-09 8:43 pm | N/A 2032-06-07 | Cortexyme Inc. | CRTX | Lamond David Director | 27,000 | $0 | 27,000 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 4:38 pm | N/A 2032-05-31 | Lucira Health Inc. | LHDX | Lamond David Director | 59,459 | $0 | 59,459 (Direct) | View |
| 2022-05-24 Option Award | 2022-05-26 5:17 pm | N/A 2032-05-24 | Applied Molecular Transport Inc. | AMTI | Lamond David Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-05-19 Option Award | 2022-05-23 8:09 pm | N/A N/A | Cortexyme Inc. | CRTX | Lamond David Director | 200,002 | $0 | 3,883,660 (Indirect) | View |
| 2021-06-16 Option Award | 2021-06-17 7:25 pm | N/A 2031-06-15 | Cortexyme Inc. | CRTX | Lamond David Director | 11,029 | $0 | 11,029 (Direct) | View |
| 2021-05-18 Option Award | 2021-05-20 7:05 pm | N/A 2031-05-18 | Applied Molecular Transport Inc. | AMTI | Lamond David Director | 15,175 | $0 | 15,175 (Direct) | View |
| 2021-03-04 Gift | 2021-03-23 7:13 pm | N/A N/A | Cortexyme Inc. | CRTX | Lamond David Director | 1,534,720 | $0 | 3,633,658 (Indirect) | View |
| 2021-02-09 Conversion | 2021-02-09 7:50 pm | N/A N/A | Lucira Health Inc. | LHDX | Lamond David Director | 146,385 | $0 | 271,666 (Indirect) | View |
Ownership | 2021-02-04 6:28 pm | N/A N/A | Lucira Health Inc. | LHDX | Lamond David Director | 0 | $0 | 271,666 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-11 6:38 pm | N/A N/A | Applied Molecular Transport Inc. | AMTI | Lamond David Director | 71,430 | $14 | 986,019 (Indirect) | View |
| 2020-06-09 Conversion | 2020-06-11 6:38 pm | N/A N/A | Applied Molecular Transport Inc. | AMTI | Lamond David Director | 914,592 | $0 | 986,019 (Indirect) | View |
| 2020-06-08 Option Award | 2020-06-09 8:12 pm | N/A 2030-06-07 | Cortexyme Inc. | CRTX | Lamond David Director | 11,029 | $0 | 11,029 (Direct) | View |
Ownership | 2020-06-04 7:30 pm | N/A N/A | Applied Molecular Transport Inc. | AMTI | Lamond David Director | 0 | $0 | 914,589 (Indirect) | View |
| 2020-02-10 Option Award | 2020-02-10 6:18 pm | N/A N/A | Cortexyme Inc. | CRTX | Lamond David Director | 30,000 | $50 | 1,955,165 (Indirect) | View |